Your browser doesn't support javascript.
loading
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients.
Coston, Tucker; Pophali, Prateek; Vallapureddy, Rangit; Lasho, Terra L; Finke, Christy M; Ketterling, Rhett P; Carr, Ryan; Binder, Moritz; Mangaonkar, Abhishek A; Gangat, Naseema; Al-Kali, Aref; Litzow, Mark; Zblewski, Darci; Pardanani, Animesh; Tefferi, Ayalew; Patnaik, Mrinal M.
Afiliação
  • Coston T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Pophali P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Vallapureddy R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Lasho TL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Finke CM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Ketterling RP; Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.
  • Carr R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Mangaonkar AA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Gangat N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Al-Kali A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Litzow M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Zblewski D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Pardanani A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Am J Hematol ; 94(7): 767-779, 2019 07.
Article em En | MEDLINE | ID: mdl-30964202
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielogênica Crônica BCR-ABL Positiva / Decitabina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielogênica Crônica BCR-ABL Positiva / Decitabina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article